Radiolabeling method
US7608241B2 · kind B2 · utility
0Cited by
62References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2005 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Jan 12, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Antibody binding assays and radiolabeling kits are disclosed for radiolabeling and testing therapeutic antibodies in the commercial setting. In particular, the kits are designed for making and evaluating radiolabeled anti-CD20 conjugates to be used for the treatment and imaging of B cell lymphoma tumors. All kit reagents are sterile and are designed to achieve a high level of antibody radiolabeling and product stability with results which are highly reproducible.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.